Skip to main content
GILD
NASDAQ Life Sciences

FDA Accepts Gilead's Yeztugo Application for Once-Weekly HIV Prevention, PDUFA Set for Feb 2027

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$124.08
Mkt Cap
$154.327B
52W Low
$104.46
52W High
$157.29
52W Position info
19% above low
Off High info
21% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

GILD sits 19% above its 52-week low of $104.46.

Summary

The U.S. FDA has accepted Gilead's Supplemental New Drug Application for Yeztugo, an investigational once-weekly oral pill for HIV prevention. This marks a significant regulatory milestone for a drug that could become the first long-acting oral option for HIV pre-exposure prophylaxis. The acceptance moves Yeztugo closer to potential market approval, strengthening Gilead's pipeline and future revenue prospects in the critical HIV treatment and prevention market. The PDUFA date for a decision is set for February 2, 2027.

At the time of this announcement, GILD was trading at $124.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $154.3B. The 52-week trading range was $104.46 to $157.29. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

GILD - Latest Insights

GILD
Nov 06, 2026, 12:16 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $167.82
Real-time Price: $166.49 info
Change: -$1.32 (-0.79%) info
Market Cap: $207B info
GILD
Nov 05, 2026, 10:35 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $174.57
Real-time Price: $166.49 info
Change: -$8.07 (-5%) info
Market Cap: $207B info
GILD
Oct 29, 2026, 4:03 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $165.88
Real-time Price: $166.49 info
Change: +$0.610 (+0.37%) info
Market Cap: $207B info
GILD
Oct 29, 2026, 4:02 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $164.00
Real-time Price: $166.49 info
Change: +$2.49 (+2%) info
Market Cap: $207B info
GILD
Oct 22, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $157.19
Real-time Price: $166.49 info
Change: +$9.30 (+6%) info
Market Cap: $207B info